Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTX 1-Week vs 2-Week Hold for Influenza Vaccine in RA
NCT05069714Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine in influenza, sponsored by Seoul National University Hospital. Started Oct 2021; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05069714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05069714.